CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Master Pharm SA is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Master Pharm SA
ul. Wersalska 8
Phone: +48 427126200p:+48 427126200 LODZ, 91-203  Poland Fax: +48 422505447f:+48 422505447
This company is no longer actively traded on any major stock exchange.
Business Summary
Master Pharm SA is a Poland-based company primarily engaged in the manufacture of wellbeing products. The Company specializes in designing and producing diet supplements, food for special nutritional purposes, dietary products, cosmetics, medical devices, as well as other consumables for third parties. Its activities are divided into four operating areas: Contract manufacturing, including designing technology and ingredients of products, manufacturing, packaging, labeling, and marking, among others; Preparation of product documentation, providing product specification, certificate of ingredients and technical etiquette; Import-export, trading with raw materials and food supplements, and Medical Devices, offering medical device design, tests, documentation, and registration. The Company cooperates with Adamed, Bioton, Synoptis, Polpharma, Pharmena, and Salvum, among others. The main shareholder of the Company is Max Welt Holdings Ltd.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
3/31/202212/31/2021Yes----

Industries
SIC Code Description
2099 Food preparations, not elsewhere classified
2833 Medicinal chemicals and botanical products
5122 Drugs, drug proprietaries, and druggists' sundries
5169 Chemicals and allied products, not elsewhere classified
6719 Offices of holding companies, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Independent Chairman of the Supervisory Board Marcin B.Konarski 40 7/14/2015 7/14/2015
Chairman of the Management Board JacekFranasik 10/25/2002 10/25/2002
Independent Member of the Supervisory Board Stanislaw F.Klimczak 73 6/25/2018 7/14/2015
Member of the Supervisory Board Jan M.Franasik 74 9/28/2015 9/28/2015
Member of the Supervisory Board RafalJaskol 6/24/2020 6/24/2020

General Information
Outstanding Shares: 19,788,614 (As of 3/31/2022)
Stock Exchange: WAR
Fax Number: +48 422505447


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, March 25, 2024